Loading…
Vir Biotechnology, Inc. is projected to rise to $11.87 by 2027, a +30% move from its current price of $9.10. VIR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $8.86 | $9.10 | $9.34 | 0.00% |
| May 30 | $8.77 | $9.10 | $9.44 | 0.00% |
| May 31 | $8.70 | $9.10 | $9.52 | 0.00% |
| Jun 1 | $8.64 | $9.10 | $9.59 | 0.00% |
| Jun 2 | $8.58 | $9.10 | $9.65 | +0.01% |
| Jun 3 | $8.53 | $9.10 | $9.70 | +0.01% |
| Jun 4 | $8.49 | $9.10 | $9.75 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.49 | $9.10 | $9.75 | +0.01% |
| Week 2 | $8.25 | $9.10 | $10.04 | +0.01% |
| Week 3 | $8.07 | $9.10 | $10.26 | +0.02% |
| Week 4 | $7.92 | $9.10 | $10.46 | +0.03% |
| Week 5 | $7.79 | $9.10 | $10.63 | +0.04% |
| Week 6 | $7.68 | $9.10 | $10.79 | +0.04% |
| Week 7 | $7.58 | $9.10 | $10.94 | +0.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.
Its preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. Vir Biotechnology has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc.
was incorporated in 2016 and is headquartered in San Francisco, California.
Vir Biotechnology, Inc. (VIR) operates in the Healthcare sector. The current price is $9.19 and the stock trades with a market capitalization of $1.55B. Its rank by market cap is 2206.
A major floor 34.1% below — a decisive break under it would weaken the trend.
The nearest floor, 6.3% below — buyers have tended to step in here.
The nearest ceiling, 21.9% above — a clean break opens room to run.
A major ceiling 33.3% above — clearing it would confirm fresh momentum.
Key VIR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VIR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.12 | Sell | $9.12 | Sell |
| MA 10 | $9.01 | Buy | $9.15 | Sell |
| MA 20 | $9.40 | Sell | $9.32 | Sell |
| MA 50 | $9.53 | Sell | $9.31 | Sell |
| MA 100 | $8.64 | Buy | $8.70 | Buy |
| MA 200 | $7.11 | Buy | $7.89 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.28 | Neutral |
| Stoch RSI (14) | 72.18 | Neutral |
| CCI (20) | -45.10 | Neutral |
| Williams %R (14) | -34.48 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -0.22 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 65.52 | Neutral |
| TRIX (15) | -0.29 | Sell |
| Awesome (5,34) | -0.66 | Sell |
| Ultimate (7,14,28) | 50.15 | Neutral |
| Momentum (10) | -0.30 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 9.31 | Sell |
| ADX (14) | 14.95 | Neutral |
| ATR (14) | 0.24 | Info |
The 30-day technical picture leans bullish with RSI14 at 50. The stock trades above the SMA200 at $7.07 and near the SMA50 at $9.54, suggesting a constructive near-term setup.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.79 | $9.10 | $12.65 | 0% | Neutral | |
| $9.45 | $11.87 | $15.77 | +30% | Bullish | |
| $9.55 | $12.31 | $16.93 | +35% | Bullish | |
| $10.53 | $13.87 | $19.60 | +52% | Bullish | |
| $10.87 | $14.59 | $21.11 | +60% | Bullish | |
| $11.36 | $15.53 | $22.92 | +71% | Bullish | |
| $13.53 | $18.80 | $28.26 | +107% | Bullish | |
| $14.94 | $21.08 | $32.22 | +132% | Bullish | |
| $16.99 | $24.32 | $37.74 | +167% | Bullish | |
| $18.93 | $27.49 | $43.26 | +202% | Bullish | |
| $25.63 | $39.64 | $66.23 | +336% | Bullish | |
| $44.11 | $76.06 | $138.66 | +736% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.79 | $9.10 | $10.71 | +0.00% |
| June 2026 | $7.75 | $9.09 | $10.92 | -0.07% |
| July 2026 | $7.70 | $9.11 | $11.08 | +0.16% |
| August 2026 | $7.91 | $9.41 | $11.56 | +3.34% |
| September 2026 | $7.93 | $9.49 | $11.75 | +0.84% |
| October 2026 | $7.79 | $9.37 | $11.69 | -1.27% |
| November 2026 | $7.96 | $9.61 | $12.07 | +2.54% |
| December 2026 | $8.26 | $10.01 | $12.65 | +4.18% |
Click any year to see its month-by-month VIR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VIR price prediction for 2026 points to an average of $9.10 (low $5.79, high $12.65) — a potential gain of 0% on today's $9.10. Price action looks broadly range-bound.
In 2027, VIR is projected to trade between $9.45 and $15.77, averaging $11.87 — a potential gain of +30% from today's $9.10. That is up +30% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Vir Biotechnology, Inc.'s 2028 outlook centres on $12.31, within a $9.55 to $16.93 range. That is up +4% on the projected 2027 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2029, VIR could reach as high as $19.60, with a base case around $13.87 and support toward $10.53 — roughly +52% from $9.10. Buyers look set to stay in control over this stretch.
Expect VIR to range from $10.87 to $21.11 through 2030. The $14.59 average target implies a +60% move from current prices. That is up +5% on the projected 2029 average. Momentum favours further upside here.
The VIR price prediction for 2031 points to an average of $15.53 (low $11.36, high $22.92) — a potential gain of +71% on today's $9.10. Buyers look set to stay in control over this stretch.
In 2032, VIR is projected to trade between $13.53 and $28.26, averaging $18.80 — a potential gain of +107% from today's $9.10. That is up +21% on the projected 2031 average. Momentum favours further upside here.
Vir Biotechnology, Inc.'s 2033 outlook centres on $21.08, within a $14.94 to $32.22 range. That is up +12% on the projected 2032 average. That marks a +132% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, VIR could reach as high as $37.74, with a base case around $24.32 and support toward $16.99 — roughly +167% from $9.10. Momentum favours further upside here.
Expect VIR to range from $18.93 to $43.26 through 2035. The $27.49 average target implies a +202% move from current prices. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The VIR price prediction for 2040 points to an average of $39.64 (low $25.63, high $66.23) — a potential gain of +336% on today's $9.10. Momentum favours further upside here.
In 2050, VIR is projected to trade between $44.11 and $138.66, averaging $76.06 — a potential gain of +736% from today's $9.10. That is up +92% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in VIR today (≈ 109.89011 VIR) could be worth
$8,358.37
+$7,358.37 (+736%) by 2050 · US Dollar
Based on the average projected VIR price of $76.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VIRwould be worth at today's price.
$1,000 invested in VIR on May 27, 2025 (≈ 214.592282 VIR) would be worth
$1,952.79
+$952.79 (+95.3%) today · 1.95× · US Dollar
Based on a VIR entry price of $4.66 vs. today's $9.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.88 | $1,024.77 | +2.5% |
| 1 month ago | $10.64 | $855.26 | -14.5% |
| 3 months ago | $9.32 | $976.39 | -2.4% |
| 6 months ago | $6.42 | $1,417.45 | +41.7% |
| 1 year ago | $4.66 | $1,952.79 | +95.3% |
| All time (5.0y) ago | $41.61 | $218.7 | -78.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VIR forecast.
Our base-case forecast reaches $18.00 around 2032.
Implied market cap at $18.00: $3.04B
The multi-year forecast shows a rising path for Vir Biotechnology. In 2026 the avg price is $9.19 with a min of $5.79 and a max of $12.90 (ROI 0; sentiment NEUTRAL). By 2027 the avg targets climb to $12.06 (min $9.58, max $16.09; ROI 31.3; sentiment BULLISH) and continue higher through 2035 with an avg of $28.96 (ROI 215.2; sentiment BULLISH).
The forecast reaches 2040 with an avg of $42.52 (min $27.27, max $71.53; ROI 362.7; sentiment BULLISH) and 2050 with an avg of $81.52 (min $46.75, max $149.82; ROI 787; sentiment BULLISH). These figures imply a long-run bullish tilt, with the max price reaching $149.82 by 2050. These are estimates, not guarantees, and could be affected by market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $15.04, with a min of $11.15 and a max of $21.86; ROI 63.7; sentiment BULLISH.
The outlook becomes progressively bullish after 2026, with 2027 avg $12.06 rising to 2050 avg $81.52 and ROI reaching 787; 2026 is Neutral. These are estimates and not guarantees.
Yes. The forecasted max price by 2050 is $149.82, with 2040 max $71.53 and 2050 avg $81.52, indicating the potential to exceed $100 under the upper-path scenario.
The 2026 min is $5.79, avg is $9.19, and max is $12.90; ROI 0; sentiment Neutral.
For 2050, the forecast shows min $46.75, avg $81.52, max $149.82; ROI 787; sentiment BULLISH.
Vir Biotechnology, Inc. Community Discussion
0Share your Vir Biotechnology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.